[go: up one dir, main page]

MY173606A - Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease - Google Patents

Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Info

Publication number
MY173606A
MY173606A MYPI2017703107A MYPI2017703107A MY173606A MY 173606 A MY173606 A MY 173606A MY PI2017703107 A MYPI2017703107 A MY PI2017703107A MY PI2017703107 A MYPI2017703107 A MY PI2017703107A MY 173606 A MY173606 A MY 173606A
Authority
MY
Malaysia
Prior art keywords
treatment
prophylaxis
dry eye
synthetic peptide
eye disease
Prior art date
Application number
MYPI2017703107A
Inventor
Yeou-Ping Tsao
Tsung-Chuan Ho
Original Assignee
Mackay Memorial Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mackay Memorial Hospital filed Critical Mackay Memorial Hospital
Priority to MYPI2017703107A priority Critical patent/MY173606A/en
Priority claimed from PCT/CN2015/073257 external-priority patent/WO2016134498A1/en
Publication of MY173606A publication Critical patent/MY173606A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein are synthetic peptides and compositions comprising the same for the treatment and/ or prophylaxis of an ocular disease, particularly, dry eye disease. Also disclosed herein are methods of treating and/ or preventing an ocular disease by administering to a subject in need of such treatment a composition containing a synthetic peptide of the present disclosure.
MYPI2017703107A 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease MY173606A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2017703107A MY173606A (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2015/073257 WO2016134498A1 (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
MYPI2017703107A MY173606A (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Publications (1)

Publication Number Publication Date
MY173606A true MY173606A (en) 2020-02-10

Family

ID=79877101

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017703107A MY173606A (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Country Status (1)

Country Link
MY (1) MY173606A (en)

Similar Documents

Publication Publication Date Title
MX392028B (en) VACCINES FOR THE TREATMENT AND PREVENTION OF CANCER.
MX2016012574A (en) Substituted heteroaryl compounds and methods of use.
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201791168A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VASCULAR EYE DISEASES
MX389242B (en) COMPOUNDS FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISORDERS
JO3564B1 (en) Peptides and formulations to treat joint damage
PH12017500922A1 (en) Stabilized omega-3 ophthalmic compositions
MY194448A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
MX2022002635A (en) Angiopoietin-like 4 antibodies and methods of use.
PH12017500615B1 (en) Ophthalmic composition comprising cyclosporine and trehalose
PH12017500098A1 (en) Suspension compositions of cyclosporin a for subconjunctival and periocular injection
PH12021550122A1 (en) Solubilized apyrases, methods and use
MX373409B (en) COMPOSITIONS FOR KERATIN FIBERS.
MX2016000448A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
MX2020000636A (en) Synthetic proteins and therapeutic uses thereof.
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
MX2019004179A (en) Apilimod compositions and methods for using same in the treatment of alzheimer's disease.
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
MY173606A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
WO2015200768A3 (en) Pharmacologic treatments of menière's disease
EA201892389A1 (en) OPHALMOLOGICAL COMPOSITION CONTAINING THE SYNERGISTIC COMBINATION OF GLYCOGEN AND HYALURONIC ACID OR ITS SALT
MX2018015240A (en) Compositions comprising timolol and their use in the treatment of rosacea by topical administration.